Found 29 matching trials
Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of SPD422 (Anagrelide Hydrochloride) in Healthy Adult Participants PHASE1 This Phase 1, open-label, single-sequence, non-randomized, multiple-dose, c...
Show More Location
New Orleans Center for Clinical Research
Learn More & Join Trial
Effect of SPD422 on Platelet Lowering and Safety in Japanese Adults With At Risk Essential Thrombocythaemia PHASE3 The purpose of this study is to investigate how effective and safe SPD422 (...
Show More Location
Akita University Hospital
Learn More & Join Trial
The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia PHASE2 The Philadelphia chromosome negative myeloproliferative neoplasms (MPN) com...
Show More Status
Active Not Recruiting
Location
UniversitÀtsmedizin Mannheim III. Medizinische Klinik HÀmatologie und Internistische Onkologie
Learn More & Join Trial
The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET) PHASE2 Age related differences in response to a drug could arise from variation in...
Show More Learn More & Join Trial
Efficacy of Momelotinib Versus Best Available Therapy in Anemic or Thrombocytopenic Subjects With Primary Myelofibrosis (MF), Post-polycythemia Vera MF, or Post-essential Thrombocythemia MF PHASE3 This study is to determine the efficacy of momelotinib (MMB) versus best av...
Show More Location
Multiple Locations
Learn More & Join Trial
Anagre Cap. in Patients With High-Risk Essential Thrombocythemia PHASE4 This study is to evaluate the efficacy and safety according to incremental ...
Show More Location
National Health Insurance Service Ilsan Hospital
Learn More & Join Trial
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272) PHASE2 The purpose of this study is to evaluate the efficacy and safety of ruxolit...
Show More Learn More & Join Trial
Anagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia PHASE3 This is a multicenter, phase III, randomized, subject and sponsor-blinded, ...
Show More Location
Uniklinik Innsbruck
Learn More & Join Trial
Nilotinib as First-line Treatment of Ph+ CML in Early Chronic Phase PHASE2 Treating Ph pos CML with Imatinib is very effective since the majority of t...
Show More Location
Dipartimento Area Medica P.O.
Learn More & Join Trial
A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants With Previously Treated Myelofibrosis PHASE2 This is a Phase 2, multicenter, two-arm, open-label study to evaluate the s...
Show More Status
Active Not Recruiting
Location
The Oncology Institute of Hope and Innovation
Learn More & Join Trial